论文部分内容阅读
目的探讨干扰素联合可必特、普米克令舒雾化治疗小儿喘憋性肺炎的临床疗效及其护理措施。方法选择2014年3月~2015年3月在我院儿科住院治疗的喘憋性肺炎患儿100例,将其随机分为观察组和对照组,对照组用布地奈德、可必特雾化吸入治疗,观察组呼吸道合胞病毒抗体均阳性,加用干扰素雾化吸入治疗,比较两组患儿疗效。结果观察组患儿疗效高于对照组(P<0.025),症状和体征缓解时间以及住院时间短于对照组(P<0.001)。结论干扰素联合布地奈德、可必特雾化吸入治疗小儿喘憋性肺炎,具有显著的疗效,能缩短其症状、体征缓解的时间,缩短病程。正确有效的护理措施有助于促进患儿的早期康复。
Objective To investigate the clinical efficacy and nursing measures of interferon combined with bilirubin and pulmicort respules in the treatment of children with asthmatic pneumonia. Methods 100 cases of children with asthmatic pneumonia treated in pediatric department from March 2014 to March 2015 were randomly divided into observation group and control group. The control group was given Budesonide Inhalation therapy, the observation group of respiratory syncytial virus antibodies were positive, plus interferon inhalation therapy, the efficacy of two groups of children were compared. Results The efficacy of observation group was higher than that of control group (P <0.025), symptom and symptom relief time and hospitalization time were shorter than that of control group (P <0.001). Conclusions Interferon combined with budesonide can treat nebulous pneumonia in children with nebulized inhalation. It has significant curative effect, shortens the time of symptom and symptom relief and shortens the course of disease. Correct and effective care can help promote early recovery in children.